Next Generation Sequencing (NGS) Solution Market Size, Share, Growth, and Industry Analysis by Type (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing and Resequencing Centrifuges‎), by Application (Sporadic Cancer, Inherited Cancer, Companion Diagnostics, Others), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET OVERVIEW

The global next generation sequencing solution market size was valued at approximately USD 4.90 billion in 2024 and is expected to reach USD 17.77 billion by 2033, growing at a compound annual growth rate (CAGR) of about 15.4% from 2025 to 2033.

The next-generation sequencing (NGS) market is an evolving technology that has developed the life sciences and diagnostics fields. It is also referred to as high data sequencing. NGS is a powerful procedure for swiftly sequencing DNA and RNA. The expansion of tailored medicine, improvements in pre-sequencing technologies, NGS bioinformatics solutions, and cloud computing present substantial progression opportunities for the global NGS market.

Participants are fixing their efforts on encouraging R&D. Technological development are supporting the regional market growth. Companies need to stay updated with varying market trends and develop products that meet rising consumer needs. Companies coming up with advanced technological solutions for firming their positions.

COVID-19 IMPACT

Pandemic Hampered The Market Due To Unexpected Disruption In The Sector

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

COVID- 19 pandemic has tremendously affected the complete world. It caused many unexpected disruption and affected the industry. COVID- 19 had negative impact on the market due to economic slowdown, unpredictability in financial sector and high unstable market. The pandemic resulted in decreased demand due to a disrupted supply chain, drop in sales of products, delivery schedules. Travel bans imposed affected business collaboration and partnership. Demand had recently reduced due to travel bans and lockdown during the COVID-19 pandemic. The continuous loss in the business due to the lockdown measures is projected to directly influence the growth of the investments in the market.

LATEST TRENDS

Use Of Innovative Products To Boost The Market Growth

Technological improvement and development will further enhance the presentation of the product, allowing it to obtain a varied range of requests in the market. Technological advancement will improve performance and propel the market growth. Technological advancement with high demand are increasingly setting a force to increase the productivity. Some players focus on product improvement to meet consumer requirements and likings. Constant innovation in manufacturing of products is anticipated to stimulate product demand.

Request a Free sample to learn more about this report

NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET SEGMENTATION 

By Type

According to type, the market can be segmented into whole genome sequencing, whole exome sequencing, targeted sequencing and resequencing centrifuges

Whole genome sequencing will capture the maximum market share through forecast period.  

• Whole genome sequencing: Whole genome sequencing comprises sequencing the complete genome, providing a comprehensive view of all genetic differences.

• Whole exome sequencing: It is mainly used in clinical diagnostics for classifying genetic causes of monogenic ailments, cancer genomics, and other circumstances where coding region mutations are associated.

• Targeted sequencing and resequencing centrifuges: Targeted sequencing includes sequencing precise genes or regions of interest frequently using panels planned for specific diseases or research areas.

By Application

According to application, the market can be segmented into sporadic cancer, inherited cancer, companion diagnostics, others

Next generation sequencing (NGS) solution market players cover segment as sporadic cancer will dominate the market share during forecast period.

• Sporadic cancer: NGS is used to examine genetic mutations in sporadic cancers. It permits the finding of new cancer-related mutations, benefits in the development of targeted healings, and supports accuracy oncology.

• Inherited cancer: It provides a tactile shopping knowledge where consumers can see and test the product previously purchasing.

• Companion diagnostics

DRIVING FACTORS

Increasingly Used In Various Applications To Boost The Market Growth

NGS is gradually used for genetic testing, cancer diagnostics, and tailored medication, motivated by the need for accurate and speedy genomic information. Pharmaceutical companies operate NGS for target finding, biomarker identification, and patient stratification in clinical trials.

Technological Advancement and Innovation To Upsurge The Market

Technological advancements and innovation activate unique revenue augmenting opportunity which will upsurge the next generation sequencing (NGS) solution market growth. Growing investment in research and development activities and growing awareness about benefits are expected to deliver profitable opportunities for the market. Improvements such as better-quality sequencing chemistries, higher-density flow cells, and progressive data study tools have expressively augmented the data and exactness of NGS technologies.

RESTRAINING FACTOR

High Cost To Hamper The Market Growth

The achievement of NGS platforms and the launch of the essential infrastructure need significant initial investments which can be a hurdle for smaller institutes. Budgets associated with consumables, upkeep, and data analysis software stay high, impacting the complete affordability of NGS.

• Request a Free sample to learn more about this report

•  

NEXT GENERATION SEQUENCING (NGS) SOLUTION REGIONAL INSIGHTS

North America to Dominate the Region Due To Rising Government Support

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East and Africa. 

North America is further expected to witness growth in the next generation sequencing (NGS) solution market share. The region is dominating the market due to increasing government support towards research & development. The rising inhabitants and increasing income levels are also contributing to the development of the market. Upsurge in investments by key market players for the R&D undertakings and enlargement of their production abilities and product portfolios are projected to upsurge the growth. The expansion of regional market is being aided by technological developments.

KEY INDUSTRY PLAYERS

Key Players Focus On Partnerships To Gain Competitive Advantage

The key players are dynamically contributing in strategic events that are aimed at maintaining strong market position and increasing market share by merger, partnerships and others. Key players are motivated to introduce new innovative products. They are spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market. The market changes are dynamic such as market expansion, partnership and merger. The collective efforts of these major players expressively impact the competitive landscape and future path of the market.

List Of Top Next Generation Sequencing Solution Companies

• Eurofins Scientific (Germany)
• Illumina (U.S.)
• Thermo Fisher Scientific (U.S.)
• Myriad Genetics (U.S.)
• Foundation Medicine (U.S.)

INDUSTRIAL DEVELOPMENT

March 2022:  Thermo Fisher Scientific declared the launch of CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that provides outcomes in as little as a single day.

REPORT COVERAGE

The report provides scrutiny and information according to market sectors. Business overview, financial overview, product portfolio, new project launch, recent development enquiry are the factors included in the profile. The report incorporates completely examined and appraised evidence of the noticeable players and their position in the market by methods for various descriptive tools. The report covers national and regional level market size and forecast. The report gives businesses the facility to research new prospect in many areas. The report shows to be an operational tool that players can use to gain a competitive superiority over their opponents and ensure lasting achievement in the market.